Cullinan Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cullinan Therapeutics Inc.
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Cullinan Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cullinan Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cullinan Therapeutics Inc. is CGEM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cullinan Therapeutics Inc. has its primary listing on NASDAQ. You can trade Cullinan Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cullinan Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Cullinan Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Cullinan Therapeutics Inc. or others.